1. 18PCombination treatment with the PARP inhibitor niraparib and chemotherapeutics in a preclinical model of KRAS/BRAF mutated colorectal cancer cell lines across the four consensus molecular subtypes. (23rd October 2018) Authors: Vitiello, P P; Cardone, C; Ciardiello, D; Belli, V; Matrone, N; Borrelli, C; Poliero, L; De Falco, V; Giunta, E F; Vitale, P; Zanaletti, N; Tirino, G; Troiani, T; Ciardiello, F; Martinelli, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 25PFunctional inhibition of TGF-β in colorectal cancer cells and its interaction with AXL receptor. (23rd October 2018) Authors: Ciardiello, D; Martini, G; Matrone, N; Belli, V; Vitiello, P P; Cardone, C; Ciaramella, V; Barra, G; Poliero, L; Borrelli, C; Troiani, T; Melisi, D; Morgillo, F; Giunta, E F; De Falco, V; Ciardiello, F; Martinelli, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 33PA new natural compound identified through a metabolomic approach has cytotoxic activity against human colorectal cancer cell lines with acquired resistance to cetuximab. (23rd October 2018) Authors: De Falco, V; Giunta, E F; Belli, V; Matrone, N; Napolitano, S; Martinelli, E; Vitale, P; Zanaletti, N; Terminiello, M; Vitiello, P P; Ciardiello, F; Troiani, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 596PCombined inhibition of MEK and PI3KCA pathway induces synergic antitumor activity in HER2 amplified human colorectal cancer models. (23rd October 2018) Authors: Belli, V; Matrone, N; Napolitano, S; Martinelli, E; Castellone, M D; Trusolino, L; Giunta, E F; De Falco, V; Zanaletti, N; Vitiello, P P; Ciardiello, D; Terminiello, M; Ciardiello, F; Troiani, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 598PMacrophage migration inhibitory factor overexpression is a mechanism of acquired resistance to anti-EGFR inhibitor cetuximab in human colorectal cancer cell line. (23rd October 2018) Authors: Matrone, N; Chambery, A; Russo, R; Pedone, P V; Belli, V; Napolitano, S; Martinelli, E; Giunta, E F; De Falco, V; Zanaletti, N; Vitale, P; Terminiello, M; Cardone, C; Ciardiello, F; Troiani, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 66PDual inhibition of TGF-β and AXL as a novel treatment for colorectal cancer. (1st October 2019) Authors: Ciardiello, D; Belli, V; Cardone, C; Vitiello, P P; Martini, G; Poliero, L; Borrelli, C; Arrichiello, G; Ciaramella, V; Matrone, N; Barra, G; De Falco, V; Giunta, E F; Morgillo, F; Troiani, T; Terminiello, M; Melisi, D; Ciardiello, F; Martinelli, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 98PIdentification of a highly suppressive Treg subset associated to immunotherapy response. (23rd October 2018) Authors: Giunta, E F; Romano, S; D'Arrigo, P; Rea, A; Tufano, M; Matarese, G; Procaccini, C; Novizio, N; Vigorito, V; Faicchia, D; Argenziano, G; De Falco, V; Ciardiello, F; Romano, M F; Troiani, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗